Ir para o conteúdo principal

United States Últimas notícias

Todas as matérias desta categoria, das mais recentes às mais antigas.

Grafa
Technology

Avantor revenue holds steady at $1.58B as high-margin segments support margins

Avantor (NYSE:AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, reported financial results for the first quarter ended March 31, 2026.

Leia mais: Avantor revenue holds steady at $1.58B as high-margin segments support margins
Grafa

Henlius and Organon secure EC approval for POHERDY, Europe’s first Pertuzumab biosimilar

Shanghai Henlius Biotech and Organon (NYSE:OGN) announced on Wednesday, April 29, 2026, that the European Commission (EC) has granted marketing authorization for POHERDY (pertuzumab), making it the first and only approved biosimilar to the reference product PERJETA in Europe.

Leia mais: Henlius and Organon secure EC approval for POHERDY, Europe’s first Pertuzumab biosimilar